In the quest to uncover the origins for SARS-CoV-2, scientists did not have to look very far. For years, the National Institutes of Health, in cooperation with EcoHealth Alliance and the [.]
Coronavirus - Brevets sur les vaccins: désaccord entre Berlin et Washington lematin.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lematin.ch Daily Mail and Mail on Sunday newspapers.
Sunshine Biopharma Upgrades COVID-19 Provisional Patent Application to Full PCT Application
May 04, 2021 08:00 ET | Source: Sunshine Biopharma Inc. Sunshine Biopharma Inc. Montreal, Quebec, CANADA
MONTREAL, May 04, 2021 (GLOBE NEWSWIRE) Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, today announced that it has timely filed a nonprovisional patent application in the form of a PCT in the United States for its COVID-19 treatment under development. Sunshine had originally filed a provisional patent application covering the COVID-19 treatment on May 22, 2020. This priority date has been maintained in the newly filed PCT application.